Genetic Screening for Gynecological Cancer: Where are We Heading?
- 7 December 2015
- journal article
- research article
- Published by Taylor & Francis in Future Oncology
- Vol. 12 (2) , 207-220
Abstract
The landscape of cancer genetics in gynecological oncology is rapidly changing. The traditional family history-based approach has limitations and misses >50% mutation carriers. This is now being replaced by population-based approaches. The need for changing the clinical paradigm from family history-based to population-based BRCA1/BRCA2 testing in Ashkenazi Jews is supported by data that demonstrate population-based BRCA1/BRCA2 testing does not cause psychological harm and is cost effective. This article covers various genetic testing strategies for gynecological cancers, including population-based approaches, panel and direct-to-consumer testing as well as the need for innovative approaches to genetic counseling. Advances in genetic testing technology and computational analytics have facilitated an integrated systems medicine approach, providing increasing potential for population-based genetic testing, risk stratification, and cancer prevention. Genomic information along-with biological/computational too...Keywords
This publication has 89 references indexed in Scilit:
- Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled TrialJNCI: Journal of the National Cancer Institute, 2014
- Population-based screening for breast and ovarian cancer risk due toBRCA1andBRCA2Proceedings of the National Academy of Sciences, 2014
- Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish WomenJournal of Clinical Oncology, 2010
- Genetic epidemiology of BRCA mutations – family history detects less than 50% of the mutation carriersEuropean Journal of Cancer, 2007
- Evaluation of models to predict BRCA germline mutationsBritish Journal of Cancer, 2006
- Screening for Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) among Endometrial Cancer PatientsCancer Research, 2006
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population‐based studyInternational Journal of Cancer, 2003
- Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israelGynecologic Oncology, 2003
- Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast CancerJNCI: Journal of the National Cancer Institute, 1999